Sig Brokerage, LP Cytokinetics Inc Transaction History
Sig Brokerage, LP
- $3.83 Trillion
- Q2 2025
A detailed history of Sig Brokerage, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Sig Brokerage, LP holds 7,500 shares of CYTK stock, worth $466,875. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,500Holding current value
$466,875% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
384Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.1 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$913 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$746 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$487 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$397 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.86B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...